Cardiometabolic Disorders News

Nearly half of people with type 2 diabetes said it is more difficult to manage their condition during the holiday season than at other times, according to a survey from the American Heart Association and American Diabetes Association.

Women with irregular menses are 20% more likely to develop cardiovascular disease and 17% more likely to develop type 2 diabetes over 20 years compared with women with regular menstrual cycles, according to an Australian database analysis.

People with type 2 diabetes and a hearing or vision impairment have an elevated risk for myocardial infarction, stroke and all-cause mortality, according to study findings published in the Journal of Diabetes Investigation.

Semaglutide and other obesity medications that can induce weight loss of at least 10% can change the way providers approach the treatment of obesity, according to a speaker.

The risk for cardiovascular events is higher for adults with type 2 diabetes who have chronic kidney disease or other risk factors, even without the presence of cardiovascular disease, according to data published in Diabetic Medicine.

Among older adults, three measures of adiposity conferred elevated risk for HF in patients with diabetes but not in those without diabetes, according to data published in Circulation.

Vitamin D and thyroid hormones are important modulators in the treatment of cardiometabolic disease and should be incorporated into clinical decision making, according to a speaker.

Mineralocorticoid receptor antagonists, particularly the most recently approved agent finerenone, should play a “central role” in the treatment of diabetic kidney disease and its related cardiovascular consequences, according to a speaker.

Providers should closely monitor people with diabetes and other high-risk adults for nonalcoholic fatty liver disease and consider multiple noninvasive tests to detect the presence of advanced fibrosis, according to a speaker.

Children with obesity and a high level of liver fat content are more likely to have impaired glucose tolerance, prediabetes and type 2 diabetes compared with those with normal liver fat content, according to a speaker